Premium
SURVIVAL FOLLOWING FIRST RELAPSE IN YOUNGER PATIENTS WITH MANTLE CELL LYMPHOMA
Author(s) -
Karmali R.,
Donovan A.,
WagnerJohntson N.,
Messmer M.,
Mehta A.,
Anderson J. K.,
Reddy N.,
Kovach A. E.,
Landsburg D. J.,
Glenn M.,
Inwards D. J.,
Ristow K.,
Lansigan F.,
Kaplan J. B.,
Caimi P. B.,
Rajguru S.,
Evens A.,
Klein A.,
Umyarova E.,
Amengual J. E.,
Lue J. K.,
Diefenbach C.,
Epperla N.,
Barta S. K.,
HernandezIlizaliturri F. J,
Handorf E.,
Villa D.,
Gerrie A. S.,
Li S.,
Mederios J.,
Wang M.,
Cohen J.,
Calzada O.,
Churnetski M.,
Hill B.,
Sawalha Y.,
Gerson J. N.,
Kothari S.,
Vose J. M.,
Bast M.,
Fenske T. S.,
Narayana Rao Gari S.,
Maddocks K. J.,
Bond D.,
Bachanova V.,
Kolla B.,
Chavez J.,
Shah B.
Publication year - 2021
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.60_2880
Subject(s) - medicine , mantle cell lymphoma , proportional hazards model , cohort , retrospective cohort study , median follow up , oncology , lymphoma , surgery , chemotherapy